Track the ペプチドリーム株式会社 stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, ペプチドリーム株式会社 has logged 11 public disclosures. Market capitalisation: €129.4bn. The latest transaction was filed on 23 March 2026 (Holding update). Among the most active insiders: M&G Investment Management Limited. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
Peptidream 是一家专注于开发用于制药应用的肽的公司。它在 XTKS 市场上市。